Infrequent hepatitis C virus (HCV) re-infection after sustained virological response (SVR) among current and former injection drug users (IDUS) having received treatment for HCV infection

被引：0
|
作者：
Grebely, Jason
Raffa, Jesse D.
Genoway, Kristo
Showler, Grey
Duncan, Fiona
Vijioen, Mork
Khara, Milan
DeVlaming, Stanley
Fraser, Chris
Conway, Brian
机构：
[1] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada
[2] Univ Waterloo, Dept Stat & Actuarial Sci, Waterloo, ON N2L 3G1, Canada
[3] Vancouver Coastal Hlth, Pender Community Hlth Ctr, Vancouver, BC, Canada
[4] Cool Aid Community Hlth Ctr, Victoria, BC, Canada
来源：
HEPATOLOGY | 2007年 / 46卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
296
引用
收藏
页码：370A / 371A
页数：2
相关论文
共 50 条
  • [1] Low rate of hepatitis C virus re-infection following sustained virological response among injection drug users having received treatment for HCV infection
    Grebely, J.
    Ngai, T.
    Knight, E.
    Raffa, J. D.
    Genoway, K. A.
    Showler, G.
    Duncan, F.
    Krajden, M.
    Dore, G.
    Conway, B.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2008, 23 : A338 - A338
  • [2] HEPATITIS C VIRUS (HCV) INFECTION AND RE-INFECTION IN ILLICIT DRUG USERS
    Barrieshee, Ahmed
    Tossonian, Harout
    Grebely, Jason
    Raffa, Jesse D.
    Gallagher, Lesley
    Storms, Michelle M.
    Duncan, Fiona
    DeVlaming, Stanley
    Conway, Brian
    HEPATOLOGY, 2009, 50 (04) : 666A - 666A
  • [3] Uptake of hepatitis C virus (HCV) treatment among injection drug users (IDUS) in Vancouver, Canada
    Grebely, J.
    Conway, B.
    Raffa, J.
    Lai, C.
    Krajden, M.
    Tyndall, M. W.
    JOURNAL OF HEPATOLOGY, 2006, 44 : S214 - S215
  • [4] Directly observed therapy (DOT) for the treatment of hepatitis C virus (HCV) infection in injection drug users (IDUS) - An interim analysis
    Grebely, J
    Duncan, F
    Vijoen, M
    Meagher, C
    Khara, M
    Raffa, J
    Genoway, K
    Fraser, C
    deVlaming, S
    Conway, B
    HEPATOLOGY, 2005, 42 (04) : 686A - 686A
  • [5] Management and treatment of injection drug users with hepatitis C virus (HCV) infection and HCV/human immunodeficiency virus coinfection
    Dore, GJ
    Thomas, DL
    SEMINARS IN LIVER DISEASE, 2005, 25 (01) : 18 - 32
  • [6] Predictors of Treatment for Hepatitis C Virus (HCV) Infection in Drug Users
    Reed, Carrie
    Stuver, Sherri O.
    Tumilty, Sheila
    Nunes, David
    Murray, Jessica E.
    Graham, Camilla S.
    Koziel, Margaret James
    Craven, Donald E.
    Skolnik, Paul R.
    Horsburgh, C. Robert, Jr.
    SUBSTANCE ABUSE, 2008, 29 (01) : 5 - 15
  • [7] Risk behaviors and hepatitis C virus (HCV) infection among new- and long-term injection drug users (IDUs)
    Oliveira, M. L. A.
    Oliveira, S. A. N.
    Telles, P. R.
    Hacker, M.
    Miguel, J. C.
    Do O, K. M. R.
    Yoshida, C. F. T.
    Bastos, F. I.
    JOURNAL OF CLINICAL VIROLOGY, 2006, 36 : S202 - S203
  • [8] Hepatitis C virus re-infection after viral clearance of HCV among HIV-positive patients with recent HCV infection in Taiwan
    Huang, M.
    Liu, W.
    Su, L.
    Wu, C.
    Wu, P.
    Yang, S.
    Zhang, J.
    Chang, H.
    Chang, S.
    Liu, C.
    Sun, H.
    Hung, C.
    Chang, S.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2018, 21
  • [9] Treatment uptake and outcomes among current and former injection drug users (IDUS) receiving directly observed therapy within a multidisciplinary group model for the treatment of hapatitis C virus (HCV) infection
    Genoway, Kristo
    Grebely, Jason
    Duncan, Fiona
    Viljoen, Mark
    Gallagher, Lesley
    Elliott, Doug
    Khara, Milan
    Raffa, Jesse D.
    deVlaming, Stanley
    Conway, Brian
    HEPATOLOGY, 2007, 46 (04) : 370A - 370A
  • [10] Infrequent reinfection after successful treatment for hepatitis C virus infection in injection drug users
    Backmund, M
    Meyer, K
    Edlin, BR
    CLINICAL INFECTIOUS DISEASES, 2004, 39 (10) : 1540 - 1543
12345